Skip to content
value.today

Daktari Diagnostics, Inc.

Total raised
$52 M
5 rounds on record
Latest round
$23 M
Mar 2015
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Daktari Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2015$23 MNo. 5$10 to $50 million

Daktari Diagnostics, Inc.: Raise no. 5, Mar 2015

Investors in this round

31 investors had bought by the notice of May 25, 2016: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Donald Hawthorne · Executive Officer, Director
  • Aaron Sandoski · Director
  • David Rubin · Director
  • Peter Kaspar · Director
  • Thierry Bernard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Donald Hawthorne, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed May 25, 2016. Read the notice at the SEC.

equitySEC
Apr 2013$20 MNo. 4$10 to $50 million

Daktari Diagnostics, Inc.: Raise no. 4, Apr 2013

Investors in this round

27 investors had bought by the notice of Apr 7, 2014: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • William Rodriguez · Executive Officer, Director
  • Aaron Sandoski · Director
  • Christopher Earl · Director
  • David Rubin · Director
  • Edward Roberts · Director
  • Roger Kitterman · Director
  • Stanley Lapidus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Rodriguez, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 7, 2014. Read the notice at the SEC.

equitySEC
Dec 2011$5 MNo. 3$2 to $10 million

Daktari Diagnostics, Inc.: Raise no. 3, Dec 2011

Investors in this round

41 investors had bought by the notice of Dec 27, 2011: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • William Rodriguez · Executive Officer, Director
  • Aaron Sandoski · Director
  • Christopher Earl · Director
  • David Rubin · Director
  • Edward Roberts · Director
  • Roger Kitterman · Director
  • Stanley Lapidus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Rodriguez, President. Source: SEC Form D, newest notice filed Dec 27, 2011. Read the notice at the SEC.

equity, debtSEC
Nov 2010$2 MNo. 2Under $2 million

Daktari Diagnostics, Inc.: Raise no. 2, Nov 2010

Investors in this round

32 investors had bought by the notice of Nov 3, 2010: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Crowley · Executive Officer
  • William Rodriguez · Executive Officer, Director
  • Aaron Sandoski · Director
  • Edward Roberts · Director
  • Roger Kitterman · Director
  • Stanley Lapidus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Rodriguez, President. Source: SEC Form D, newest notice filed Nov 3, 2010. Read the notice at the SEC.

equitySEC
Aug 2009$3 MNo. 1$2 to $10 million

Daktari Diagnostics, Inc.: Raise no. 1, Aug 2009

Investors in this round

39 investors had bought by the notice of Aug 26, 2009: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Crowley · Executive Officer
  • William Rodriguez · Executive Officer, Director
  • Aaron Sandoski · Director
  • Edward Roberts · Director
  • Roger Kitterman · Director
  • Stanley Lapidus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William Rodriguez, President. Source: SEC Form D, newest notice filed Aug 26, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Daktari Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2016).

    SEC Form D · May 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2016

That is all the official record says: Daktari Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Daktari Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 41 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Daktari Diagnostics, Inc.
NameRoleNamed in
Donald HawthorneExecutive officerMay 2016
William RodriguezExecutive officerMar 2015
Michael CrowleyExecutive officerNov 2010
Aaron SandoskiDirectorMay 2016
David RubinDirectorMay 2016
Donald HawthorneDirectorMay 2016
Peter KasparDirectorMay 2016
Thierry BernardDirectorMay 2016
Edward RobertsDirectorMar 2015
William RodriguezDirectorMar 2015
Christopher EarlDirectorApr 2014
Roger KittermanDirectorApr 2014
Stanley LapidusDirectorApr 2014